chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lacerations on her head; Bleeding; had a weird feeling; dizziness; afraid to go upstairs; chills; nauseas; feels so weak; Might have had syncope; Minor pain at injection site; A spontaneous report  was received from a 79-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who have experienced syncope (might have had syncope), skin laceration (lacerations on her head), nausea (nauseas), vaccination site pain(minor pain at injection site), feeling abnormal (had a weird feeling), fear (afraid to go upstairs), dizziness (dizziness), chills (chills), and asthenia (feels so weak) and bleeding (was on the floor and saw blood on the floor).  The patient's medical history include fluctuating blood pressure. The patient was allergic to mono sodium  glutamate, NutraSweet, codeine and prednisone.No concomitant product use was reported.  On 09 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012M20A) intramuscularly for prophylaxis of COVID-19 infection.  It was known that the patient was scheduled to receive the second dose of vaccine on 09-Mar-2021.  On 08 Mar 2021, the patient received their second of two planned doses of mRNA-1273 (Lot number: D77727310) intramuscularly for prophylaxis of COVID-19 infection. On 08-Mar-2021, the patient experienced minor pain at the injection site, and chills during the night time. On 09-Mar-2021, the patient reported "had a weird feeling", "was on the floor and saw blood on the floor". On the same day, an unspecified duration later, the patient "passed out again" on the bed and reported that the pillow was full of blood. On 09-Mar-2021, a neck brace was placed and the patient was taken to the hospital. It was known that the patient had experienced nauseas and was sick, "almost like a blur". During the patient's stay in the hospital, over a period of 3 days, the patient reported "everything spins", experienced lacerations on the head and dizziness. The patient had surgical staples placed on head and felt very weak. The patient was "afraid to go upstairs". According to the physician the patient could have had a fever leading to the drop in the blood pressure and might have experienced syncope.   Treatment information was unknown.  Action taken with mRNA-1273 was unknown.  The outcome of the events, syncope (might have had syncope), skin laceration (lacerations on her head), nausea (nauseas), loss of consciousness (she might have passed out again), injection site pain (minor pain at injection site), illness (so sick), feeling abnormal (had a weird feeling), fear (afraid to go upstairs), dizziness (dizziness), chills (chills), asthenia (feels so weak), was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Developed petechial rash over entire body on 8/31/2007, 3-4 days after immunization with MMR and Hep A vaccines. Otherwise asymptomatic, with no site of active bleeding. Seen by my in office on 9/4/07 and sent to ER at  Hospital. Discharged home and seen by pediatric hematology at Hospital on 9/5/07 with rpeat platelet count = 5,000. Treated with WinRho but developed reaction - was admitted overnight for observation. Repeat platelet count 9/6/07 = 71,000. Discharged with follow-up 9/11/07.
tiredness; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PYREXIA (fever) and CHILLS (chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness), PYREXIA (fever) and CHILLS (chills). At the time of the report, FATIGUE (tiredness), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported. It was reported that patient received first booster dose.   This case was linked to MOD-2022-543630, MOD-2022-543615, MOD-2022-543563 (Patient Link).
RASH/SWELLING   RED/ITCHY AT INJECTION SITE 8 DAYS AFTER VACCINE ADMINISTERED VERY TIRED
Information has been received from a registered nurse referring to a patient of unknown ages and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 15-NOV-2018, the patient received ROTATEQ (lot# N005619 expiration date 29-OCT-2018) (strength, dose and frequency were not reported) orally for prophylaxis. It was confirmed the ROTATEQ did not have any temperature excursions prior to administration. No adverse symptoms reported.
Repeated vomiting of formula and baby foods, onset 4-6 ours after receipt of vaccine, duration 48 hrs. No fever or other illness symptoms immediately prior to vaccine.
Pt. had TRU and MCV yesterday then went to school, felt feverish (not taken) and nauseous after that, also noted to be pale at school; tired after and slept 12 hrs; has congestion and ST this AM, still feeling tired and fever, no SOB, no V/D, no cough.
patient fainted after vaccination maybe due to anxiety. pt was ok after 30 minutes and drank orange juice.
Hospitalized 11/18/2021; COVID-19 positive 11/18/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: MD, MPH Primary Care Provider at Discharge: MD Admission Date: 11/18/2021 Discharge Date: 11/20/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hyponatremia [E87.1] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient admitted with SOB, fevers and hypoxia down to 88%. On admission patient was started on dexamethasone. He required up to 2L of nasal cannula but weaned to room air at rest in the am of 11/20/21. Patient was still desatting to 87% with activity and so was discharged with home O2.    CONSULTS / RECOMMENDATION: Further wean O2 at home. Patient was given a pulse ox to assist with weaning at home. Goal oxygen concentration of 92%.
about 30 minutes post vaccination, pt began having tightness in her throat and itchy, raised, red rash.  her vital signs were stable, lungs were clear.  she was given oral Benadryl, inhaled albuterol (MDI and nebulizer) symptoms improved, vitals remained stable.  she felt hot and flushed, improved after wet towel to skin.  she was released at about 6pm (1.5 hrs after vaccination).
Itching at the injection site; Swelling at the injection site; Redness at the injection site; A spontaneous report  was received from a consumer concerning a 78-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swelling, redness and itching at the injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 14 Jan 2021, approximately ten days prior to the onset of the events swelling, redness and itching at the injection site, the patient received their first of two planned doses of mRNA-1273 (lot/batch number: 013620A) in the left arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient experienced swelling, redness and itching at the injection site. The patient did not receive any treatment.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events swelling, redness and itching at the injection site was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
High Fever (103-104 F), redness and extremely sore.  Left deltoid region for 4 days, hospitalized for 4 days which cost me $19,100.00 and I don't have any health insurance. I went to one of the flu shot camps on 3rd October 2006 to take the flu shot because the flu season just began.  I went there and filled out the form and ready to take flu shot when administering nurse offered if I would also like to take a pneumonia shot which cost me $40 nd total of $65 including flu shot.  But I was not aware that this pneumonia shot will cost me thousands of dollars.  In the evening of the same day I started to feel little achy and getting little temperature.  But next day in the morning I had a fever about 103 F and body was aching which prompted me to go to the emergency room.  I went there and after few hours of diagnostic and few blood tests they admitted me to the emergency room and started IV.  At this time, my left upper arm was all red and sore that one cannot even touch that part of the hand.  I stayed in the hospital for 4 days because of this pneumonia shot which nurse offered.  Doctor said at the hospital that because of the pneumonia shot there is an adverse effect which kept me in the hospital  for 4 days.  I am only 34 years old and doctor was surprised that why I would need this shot.  He said this shot is only for person above 65 years of age.  I do not have any kind of health coverage and now the hospital bill is $19,100.60.  My income is very low to pay bill.  Now who is responsible for such an event?? Drug store, manufacturer of the vaccine, or the Nurse who offered it?? Hospital MR received which revealed a previously healthy 33 yr old man who presented to the ER with fever, muscle aches, redness, swelling and pain at the site of his Pneumovax.  Admission H&P shows symptoms are consistant with cellulitis, but underlying abcess needs to be ruled out.    Infectious disease consult with the following impression: 1) Fever and leukocytosis 2) Systemic reaction to Pneumococcal vaccine 3) Local reaction and local cellulitis to the injection site 4) Allergic reaction with small hives noted. Treated with antibiotics and steroids. Discharge Summary received. By 3rd hospital day patient was afebrile, no swelling or tenderness, minimal erythema. Discharged home on prednisone to F/U in one week if any problems. DISCHARGE DIAGNOSIS: "Adverse reaction to pneumococcal vaccine, local reaction resolved."
immediately after vax patient fainted. Monitored her for 30 min. She was able to communicate with us and everything was well
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's medical history and current conditions were not reported. On 07-APR-2015, the patient was vaccinated with an improperly stored dose of (Merck) VARIVAX (dose, frequency, route of administration, lot# and expiration date were not reported). No adverse effect was reported. Product quality complain (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Over 35 days since 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Over 35 days since 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0431321A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Over 35 days since 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Over 35 days since 1st dose) had resolved.            No concomitant medications information was not reported No treatment medications were provided
Initial unsolicited report received from physician on 23 Feb 2017. This case involves three patients (age and gender not reported) who were vaccinated with a dose of FLUZONE QIV (Batch number, expiration date, dose and site of administration was not reported) via intramuscular route on an unspecified date. The patient's medical history was not reported. Any other vaccinations within 4 weeks of vaccinations and illness at time of vaccination was reported as none. On an unspecified date, following the vaccination, the patient had experienced flu like symptoms. Patient required emergency room visit. Lab data was reported as none. The patient received corrective treatment with TAMIFLU. The patients was not recovered from the event. List of documents held by sender: none.
She hold her left arm like it is in a sling. While she can extend her arm and raise her arms it is not to the full ability as before or as her right can lift currently. She has not shown any signs of discomfort unless we try to manipulate her left arm and get it to extend. Things started at 11:00am and there was no fall or incident which is obvious that started it. We noticed it when she would not lift her arm to eat. We sought medical attenion that day at 1:30pm in which the physcian put her through supination test of her arm to rule out Nurse Maids Elbow. There were not clicks, or pops and the physican was positive that he could rule out that condition.
lymph node or thyroid on the right side of neck started hurting; headache; neck tenderness since after receiving the first dose; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck tenderness since after receiving the first dose), LYMPH NODE PAIN (lymph node or thyroid on the right side of neck started hurting) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Parkinson's disease. Concomitant products included CARBIDOPA MONOHYDRATE, LEVODOPA (SINEMET) and ALPRAZOLAM (XANAX) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced NECK PAIN (neck tenderness since after receiving the first dose). On an unknown date, the patient experienced LYMPH NODE PAIN (lymph node or thyroid on the right side of neck started hurting) and HEADACHE (headache). At the time of the report, NECK PAIN (neck tenderness since after receiving the first dose) had not resolved and LYMPH NODE PAIN (lymph node or thyroid on the right side of neck started hurting) and HEADACHE (headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up received on the date 24-JUN-2021 was non significant. On 16-Jul-2021: Follow up included additional events
Narrative: Patient reports "headache that will not go away since vaccine. to have MRI this week. Tha's the only symptom so far." Patient instructed to monitor for the following symptoms over the course of three weeks after the vaccination. * A headache that occurs 6 days or more after vaccination * A headache that is different from other headache you have had * Confusion or trouble thinking clearly * Visual changes, such as blurry vision * Weakness, numbness, or trouble moving one or more parts of your body, trouble speaking or seizures * Tiny spots under the skin away from the area where you had the infection (this is a sign of low platelets) Patient instructed to contact their health care provider if one or more of these symptoms develop. If symptoms are severe, seek immediate medical attention at the closest emergency department or call 9-1-1
Fever; Aches; felt poorly; This is a spontaneous report from a contactable consumer (patient) reporting for himself. A 52-year-old female patient received second dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Lot Number: ER8130 and expiry date was unknown) via an unspecified route of administration on 25Mar2021 as single dose for covid-19 immunisation. The patient medical history included covid-19 (suspected) a year prior, but she did not get tested at that time. The patient historical vaccine included first dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine) on 03Mar2021; Lot Number: EN6199. Family history was none. Concomitant medications were not reported. The patient did not use other products. She did not receive any other prior vaccinations within 4 weeks or had AE following prior vaccination. No additional vaccines aministered on same date of the bnt162b2 vaccine. She stated that about 16 hours after her own Covid vaccine, on 26Mar2021, she had fever, aches and felt poorly for a few hours until she took some Advil. The patient declines to provide mailing address and stated that she can just be reached on the phone number provided at the beginning of the call. The declined to provide HCP information. The patient stated that she heard that if you had Covid 19 before your symptoms after the second vaccine might be worse. She stated that she did not know if that was true. She did not require emergency room visit or visit to physician's office. There were no relevant tests performed. The patient declined to speak to  and started that her doctor told her that having symptoms after the vaccine was a good thing as it shows a robust immune response. The patient received treatment with Advil for the events. The clinical outcome of the events was recovered on 26Mar2021.  No follow-up attempts are needed. No further information is expected.
Pt was given an extra dose of Shingrix unknowingly,  they had previously received 2 doses of Shingrix, a few years ago.  symptoms or events unknown
felt sleepy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (felt sleepy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J2D-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (felt sleepy). At the time of the report, SOMNOLENCE (felt sleepy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Treatment information was not provided.    This case was linked to MOD-2021-385695, MOD-2021-385680 (Patient Link).
15 min after the vaccine patient was released from the pharmacy and exactly 20 min after the vaccine patient began to experience numbness on the left side of his face and difficulty driving. When he came home he complained of numbness and loss of strength in his left arm and as the next hour progressed he began experiencing numbness in his left hip and decreasing strength in his left hand. I called a medical professional who told me to take him to call an ambulance or take him to the nearest hospital. We arrived at the hospital at 2:30pm and symptoms persisted. By the time we arrived his blood pressure had jumped to 185/114  (This morning before the shot he had self monitored his BP @ 128/80)
Pt reports eyes shifting really fast, eyes jumping, sleepy, fever, dizziness, jitters with flu shot.  He also recieved Boostrix and Pneumovax but attributes these side effects to the flu shot as they are similar to what he experienced years ago.   He is better today and expects to be fully recovered by tomorrow.
Vomiting started about 7 hours after vaccine and has continued. He has not been able to hold down solid food. He has joint pain also. No fever.
The pt experienced fever, chills, aches, redness (injection site) and swelling (joint).  As of 10/5/00, the outcome of the events is resolved.
4cm indurated area Left upper arm warm to touch, febrile 24 hours before presenting to Health unit, referred to primary care physician for evaluation.
received dose 1 / 3 years ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist reported that, the patient received first dose of Shingrix 3 years ago. Till the time of reporting, the patient did not receive the second dose, which led to incomplete course of vaccination. The reporter consented to follow up.
This is an initial spontaneous report from a non-contactable Pharmacist. Pharmacist called to make a medical information inquiry. Pharmacist is reporting on behalf of a consumer who may be having a local reaction at a (PREVNAR 13) injection site. No further information obtained. The caller states that the vaccine was given on 29Nov2014. The patient reported to the pharmacy that a couple days after the injection, the injection site gets red, swollen and itchy. The pharmacist is concern that the patient may be having an allergic reaction. The package insert indicates that the site can be red and swollen but nothing about itching. The caller added that she did not know the details and the patient will come to the pharmacy for her to take a look at it and she could call later to report after seeing the patient. No follow-up attempts possible. No further information expected.
Pt started with a red knot at the site of injection, sore and warm to the touch. It lasted approximately one week. Then 07/05/2015 she developed a blister type rash in a circular shape surrounding the area where the original reaction had occurred. The rash is itchy a warm to the touch.
pt recvd vax & started feeling bad & devel low grade fever & sinus problems; pt saw md who dx strep throat; pt devel also headache;